Question 1

Does BNP Paribas Financial Markets own VKTX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, BNP Paribas Financial Markets holds 981,700 shares of VKTX (Viking Therapeutics), worth $38.3M.

Question 2

How many shares of VKTX does BNP Paribas Financial Markets own?

Accepted Answer

As of its Q2 2026 13F, BNP Paribas Financial Markets holds 981,700 shares of VKTX (Viking Therapeutics).

Question 3

What is BNP Paribas Financial Markets' VKTX position worth?

Accepted Answer

As of its Q2 2026 13F, BNP Paribas Financial Markets' VKTX position is worth $38.3M.

Question 4

Is BNP Paribas Financial Markets buying or selling VKTX?

Accepted Answer

In Q2 2026, BNP Paribas Financial Markets increased its VKTX position by 441,201 shares (+81.6%).

Question 5

When did BNP Paribas Financial Markets first buy VKTX?

Accepted Answer

BNP Paribas Financial Markets first reported VKTX in its Q1 2019 13F and has listed it in 30 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	981,700	+81.6%	$38.3M	0.0%	$39.01	45
2026-Q1	Decreased	540,499	-45.5%	$17.6M	0.0%	$32.54	0
2025-Q4	Increased	992,695	+535.1%	$34.9M	0.0%	$35.18	47
2025-Q3	Decreased	156,309	-7.0%	$4.1M	0.0%	$26.28	0
2025-Q2	Decreased	168,023	-66.7%	$4.5M	0.0%	$26.50	0
2025-Q1	Increased	504,716	+980.7%	$12.2M	0.0%	$24.15	45
2024-Q4	Decreased	46,701	-46.1%	$1.9M	0.0%	$40.24	0
2024-Q3	Decreased	86,712	-66.2%	$5.5M	0.0%	$63.31	0